The Cost of Multimodal vs Opioid Postoperative Pain Regimens for the Foot & Ankle Surgical Patient

Category: Other; Other Introduction/ Purpose: Orthopedic surgeons are one of the highest prescribing specialties of opioids in medicine. To address the ongoing opioid crisis in the United States, many surgeons have adopted multimodal regimens for post-operative pain control to decrease the need for...

Full description

Bibliographic Details
Main Authors: William D. Kelly BS, J. Benjamin Jackson MD, MBA, Julia Bian MD
Format: Article
Language:English
Published: SAGE Publishing 2023-02-01
Series:Foot & Ankle Orthopaedics
Online Access:https://doi.org/10.1177/2473011423S00010
_version_ 1797900987113930752
author William D. Kelly BS
J. Benjamin Jackson MD, MBA
Julia Bian MD
author_facet William D. Kelly BS
J. Benjamin Jackson MD, MBA
Julia Bian MD
author_sort William D. Kelly BS
collection DOAJ
description Category: Other; Other Introduction/ Purpose: Orthopedic surgeons are one of the highest prescribing specialties of opioids in medicine. To address the ongoing opioid crisis in the United States, many surgeons have adopted multimodal regimens for post-operative pain control to decrease the need for opioids. Recent studies have demonstrated the effectiveness of opioid-sparing multimodal pain management therapies when compared to opioid inclusive therapies. However, to date there are no published studies analyzing the cost of multimodal vs opioid postoperative pain regimens for the elective foot & ankle surgical post-surgical patient. Methods: A secondary analysis of data collected from two studies that evaluated pain control after elective forefoot surgery was analyzed. The index study examined the number of opioid pills consumed post-operatively. A follow-up then examined the clinical utility of the non-opioid pain regimen for pain control post-operatively. Medications in the non-opioid multimodal regimen included cyclobenzaprine, ketorolac, meloxicam, pregabalin, and acetaminophen. Using information collected during these two studies, deidentified patient profiles were constructed using the patient’s insurance carrier and preferred pharmacy to determine the cost of each patient’s post-operative regimen (narcotics vs multimodal). All patients, 40 patients from the multimodal pain pathway study and 59 from the opioid pain control study, were included in this analysis and their prescription costs were totaled and analyzed. Results: A box plot was constructed to visualize data and identify outliers to be removed for data analysis. Prescriptions in the opioid group had an average cost of $8.92 (SD=$5.74) while the multimodal group had an average cost of $25.60 (SD=$10.49), p Conclusion: Patients whose post-operative pain was managed by an opioid-free multimodal regimen had statistically significant higher prescription costs than with opioid monotherapy regardless of health insurance type. However, the difference may not be clinically significant as on average it was $17. As more studies demonstrate the effectiveness of opioid-free post-operative pain management, it may be reassuring to surgeons that despite a greater number of medications with the multimodal protocol the average cost difference was only about $17. This information may allow surgeons to prescribe this regimen to all patients regardless of socioeconomic status and continue to decrease post-operative opioid prescriptions.
first_indexed 2024-04-10T08:54:46Z
format Article
id doaj.art-aea7b1627aa147dc95c547bd260e455a
institution Directory Open Access Journal
issn 2473-0114
language English
last_indexed 2024-04-10T08:54:46Z
publishDate 2023-02-01
publisher SAGE Publishing
record_format Article
series Foot & Ankle Orthopaedics
spelling doaj.art-aea7b1627aa147dc95c547bd260e455a2023-02-21T19:03:47ZengSAGE PublishingFoot & Ankle Orthopaedics2473-01142023-02-01810.1177/2473011423S00010The Cost of Multimodal vs Opioid Postoperative Pain Regimens for the Foot & Ankle Surgical PatientWilliam D. Kelly BSJ. Benjamin Jackson MD, MBAJulia Bian MDCategory: Other; Other Introduction/ Purpose: Orthopedic surgeons are one of the highest prescribing specialties of opioids in medicine. To address the ongoing opioid crisis in the United States, many surgeons have adopted multimodal regimens for post-operative pain control to decrease the need for opioids. Recent studies have demonstrated the effectiveness of opioid-sparing multimodal pain management therapies when compared to opioid inclusive therapies. However, to date there are no published studies analyzing the cost of multimodal vs opioid postoperative pain regimens for the elective foot & ankle surgical post-surgical patient. Methods: A secondary analysis of data collected from two studies that evaluated pain control after elective forefoot surgery was analyzed. The index study examined the number of opioid pills consumed post-operatively. A follow-up then examined the clinical utility of the non-opioid pain regimen for pain control post-operatively. Medications in the non-opioid multimodal regimen included cyclobenzaprine, ketorolac, meloxicam, pregabalin, and acetaminophen. Using information collected during these two studies, deidentified patient profiles were constructed using the patient’s insurance carrier and preferred pharmacy to determine the cost of each patient’s post-operative regimen (narcotics vs multimodal). All patients, 40 patients from the multimodal pain pathway study and 59 from the opioid pain control study, were included in this analysis and their prescription costs were totaled and analyzed. Results: A box plot was constructed to visualize data and identify outliers to be removed for data analysis. Prescriptions in the opioid group had an average cost of $8.92 (SD=$5.74) while the multimodal group had an average cost of $25.60 (SD=$10.49), p Conclusion: Patients whose post-operative pain was managed by an opioid-free multimodal regimen had statistically significant higher prescription costs than with opioid monotherapy regardless of health insurance type. However, the difference may not be clinically significant as on average it was $17. As more studies demonstrate the effectiveness of opioid-free post-operative pain management, it may be reassuring to surgeons that despite a greater number of medications with the multimodal protocol the average cost difference was only about $17. This information may allow surgeons to prescribe this regimen to all patients regardless of socioeconomic status and continue to decrease post-operative opioid prescriptions.https://doi.org/10.1177/2473011423S00010
spellingShingle William D. Kelly BS
J. Benjamin Jackson MD, MBA
Julia Bian MD
The Cost of Multimodal vs Opioid Postoperative Pain Regimens for the Foot & Ankle Surgical Patient
Foot & Ankle Orthopaedics
title The Cost of Multimodal vs Opioid Postoperative Pain Regimens for the Foot & Ankle Surgical Patient
title_full The Cost of Multimodal vs Opioid Postoperative Pain Regimens for the Foot & Ankle Surgical Patient
title_fullStr The Cost of Multimodal vs Opioid Postoperative Pain Regimens for the Foot & Ankle Surgical Patient
title_full_unstemmed The Cost of Multimodal vs Opioid Postoperative Pain Regimens for the Foot & Ankle Surgical Patient
title_short The Cost of Multimodal vs Opioid Postoperative Pain Regimens for the Foot & Ankle Surgical Patient
title_sort cost of multimodal vs opioid postoperative pain regimens for the foot ankle surgical patient
url https://doi.org/10.1177/2473011423S00010
work_keys_str_mv AT williamdkellybs thecostofmultimodalvsopioidpostoperativepainregimensforthefootanklesurgicalpatient
AT jbenjaminjacksonmdmba thecostofmultimodalvsopioidpostoperativepainregimensforthefootanklesurgicalpatient
AT juliabianmd thecostofmultimodalvsopioidpostoperativepainregimensforthefootanklesurgicalpatient
AT williamdkellybs costofmultimodalvsopioidpostoperativepainregimensforthefootanklesurgicalpatient
AT jbenjaminjacksonmdmba costofmultimodalvsopioidpostoperativepainregimensforthefootanklesurgicalpatient
AT juliabianmd costofmultimodalvsopioidpostoperativepainregimensforthefootanklesurgicalpatient